Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Syros Pharmaceuticals Inc (SYRS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Syros Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.100 +0.030    +0.59%
25/04 - Closed. Currency in USD ( Disclaimer )
After Hours
5.040
-0.060
-1.176%
19:07:56 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 128,567
  • Bid/Ask: 4.600 / 5.450
  • Day's Range: 4.920 - 5.150
Syros Pharma 5.100 +0.030 +0.59%

Syros Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Syros Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

117

Equity Type

ORD

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company’s lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 35 CambridgePark Drive 4th Floor
Cambridge, 02140
United States
Phone 617 744 1340
Fax -

Top Executives

Name Age Since Title
Peter Wirth 71 2017 Independent Chairman
Nathanael S. Gray - 2013 Scientific Founder & Member of Scientific Advisory Board
Scott A. Biller 67 2013 Member of Scientific Advisory Board
Stefan Knapp - 2013 Member of Scientific Advisory Board
Richard A. Young 69 2011 Scientific Founder, Member of Scientific Advisory Board & Director
Chris Vakoc - 2013 Member of Scientific Advisory Board
Bradley E. Bernstein - - Member of Scientific Advisory Board
Mark Murcko 63 2013 Member of Scientific Advisory Board
Robert A. Weinberg - 2013 Member of Scientific Advisory Board
Aviv Regev 52 2013 Member of Scientific Advisory Board
Gerard Evan - 2013 Member of Scientific Advisory Board
Nancy A. Simonian 62 2012 Director
Roger D. Tung 63 - Member of Scientific Advisory Board
Timothy C. Tyson 70 2022 Independent Director
Conley Chee 53 2021 CEO, President & Director
Marsha H. Fanucci 69 2015 Independent Director
Srinivas Akkaraju 55 2017 Independent Director
Andrew M. Oh 52 2022 Independent Director
Sue Gail Eckhardt 65 2020 Independent Director
Deborah Dunsire 61 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SYRS Comments

Write your thoughts about Syros Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nhat Doan
Nhat Doan Dec 06, 2023 12:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
IF BLOCK SHORT NEVER BUY MUST DELETE 👹🔥👊
Alon Oahyo
Alon Oahyo Oct 19, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next stope 0
Alon Oahyo
Alon Oahyo Oct 19, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sad story
Alon Oahyo
Alon Oahyo Sep 23, 2022 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
mother f
Alon Oahyo
Alon Oahyo Sep 23, 2022 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
60 $ in 250 years if the world will be
Alon Oahyo
Alon Oahyo Sep 23, 2022 2:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
strong buy hhhhhhh
Alon Oahyo
Alon Oahyo Sep 23, 2022 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
worst stock evere fffffff
Alon Oahyo
Alon Oahyo Sep 19, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
worst stock everfffffff.......
Alon Oahyo
Alon Oahyo Aug 04, 2022 1:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
9.8???
Seong Yun Jung
Seong Yun Jung Jun 07, 2021 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow this call option works horrible.. dont even try....drop 25
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email